Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta‐analysis

…, JA Jover, RF Spiera, C HernándezGarcía… - Arthritis & …, 2007 - Wiley Online Library
Objective To reevaluate the efficacy and safety of adjunctive low‐dose methotrexate (MTX)
in giant cell arteritis (GCA). Methods An individual patient data meta‐analysis of 3 …

Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial

JA Jover, C Hernández-García, IC Morado… - Annals of internal …, 2001 - acpjournals.org
Background: Corticosteroids remain the cornerstone of therapy for giant-cell arteritis, but
relapse during dose tapering and corticosteroid-related adverse events often complicate …

The prevalence of rheumatoid arthritis in the general population of Spain

L Carmona, V Villaverde, C HernándezGarcía… - …, 2002 - academic.oup.com
Objective. To estimate the prevalence of rheumatoid arthritis (RA) in the adult Spanish population
and to assess its distribution by basic sociodemographic characteristics. Methods. Two …

Increased risk of tuberculosis in patients with rheumatoid arthritis.

L Carmona, C Hernández-García, C Vadillo… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To quantify the risk of tuberculosis (TB) in an unselected sample of patients with
rheumatoid arthritis (RA) compared to the risk in the general population. METHODS: The …

Costs and predictors of costs in rheumatoid arthritis: a prevalence‐based study

…, B Bellajdel, C HernándezGarcía… - Arthritis Care & …, 2003 - Wiley Online Library
Objective To analyze the annual cost of rheumatoid arthritis (RA) and its predictive factors.
Methods Data were obtained from a 12‐month retrospective cohort of 201 RA patients, …

Eye involvement in the spondyloarthropathies

A Bañares, C Hernández-García… - … Disease Clinics of North …, 1998 - Elsevier
Eye inflammation may be a prominent feature of several rheumatic diseases. The
spondyloarthropathies, including ankylosing spondylitis (AS), Reiter's syndrome (RS), psoriatic …

Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.

C Hernández-García, E Vargas, L Abásolo… - The Journal of …, 2000 - europepmc.org
Objective To study demographic and clinical variables associated with a longer delay in
disease modifying antirheumatic drug (DMARD) therapy initiation in a cohort of patients with …

Uso de fármacos modificadores de la enfermedad en artritis reumatoide

CH García, CM Prada - Información terapéutica del Sistema …, 2009 - dialnet.unirioja.es
El tratamiento de la artritis reumatoide ha cambiado por el reconocimiento de que el daño
articular comienza precozmente, que a mayor evolución menor es la probabilidad de …

A health system program to reduce work disability related to musculoskeletal disorders

…, C Hernández-García… - Annals of internal …, 2005 - acpjournals.org
Background: Musculoskeletal disorders (MSDs) are a frequent cause of work disability,
accounting for productivity losses in industrialized societies equivalent to 1.3% of the US gross …

Constitución de los atenienses

CH García - … de Filología Clásica. Estudios Griegos e …, 2005 - search.proquest.com
Desde nuestro punto de vista, esta elección es de lo más acertada, pues permite al lector
extrapolar (dentro de los límites que impone la lógica) algunos términos a las instituciones …